Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Metabolism, Alcohol & Toxicity
6
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022
View
Viral Hepatitis
1
GlaxoSmithKline: Nothing about me without me - ILC 2022
